GNH USA

Europe — EMA

Mestinon

GNH USA supplies Mestinon (Pyridostigmine Bromide), an acetylcholinesterase inhibitor for myasthenia gravis. Request a quote for global supply today.

Pyridostigmine Bromide

Request sourcing

1
Pack/s

What is Pyridostigmine Bromide?

Pyridostigmine bromide, the active ingredient in Mestinon, is an acetylcholinesterase inhibitor presented as an oral formulation for oral use. It treats myasthenia gravis by enhancing neuromuscular transmission in affected individuals.

GNH USA supplies Mestinon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

What is Pyridostigmine Bromide used for?

Mestinon is an acetylcholinesterase inhibitor used to manage disorders of neuromuscular transmission. - Myasthenia gravis: Improves skeletal muscle strength by increasing acetylcholine availability at the neuromuscular junction. - Ocular myasthenia: Reduces ptosis and diplopia through enhanced cholinergic signaling in ocular muscles. - Myasthenic crisis (adjunct therapy): Supports respiratory muscle function when combined with other emergency interventions.

What are the side effects of Pyridostigmine Bromide?

Mestinon may cause a range of adverse reactions, most of which are related to excess cholinergic activity.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools. - Abdominal cramps: discomfort in the abdomen. - Increased salivation: excess saliva production.

Serious or Rare Side Effects: - Bradycardia: abnormally slow heart rate that may require medical attention. - Severe cholinergic crisis: marked muscle weakness, respiratory failure, or paralysis. - Allergic reaction: rash, itching, swelling, or anaphylaxis.

What precautions apply to Pyridostigmine Bromide?

Before initiating therapy, consider the following safety measures. - Dose titration: Adjust the dose gradually under medical supervision to minimize cholinergic side effects. - Renal impairment: Monitor renal function closely; dose reduction may be necessary. - Cardiac disease: Use cautiously in patients with bradyarrhythmias or conduction disorders. - Pregnancy: Safety not established; evaluate risk versus benefit with a healthcare provider. - Concomitant anticholinergic drugs: May diminish therapeutic effect. - Store at ambient temperature: Keep below 25°C, retain in the original packaging, and protect from moisture.

What does Pyridostigmine Bromide interact with?

Mestinon can interact with several medication classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Beta‑blockers: May exacerbate bradycardia. - Anticholinergic agents (e.g., atropine): Counteract Mestinon’s therapeutic effect. - Potassium channel blockers (e.g., quinidine): Increase risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Diuretics: May alter electrolyte balance affecting drug action. - Anesthetic agents (e.g., succinylcholine): Can potentiate neuromuscular effects. - Macrolide antibiotics: Possible additive cholinergic activity.

Frequently asked questions

What is Mestinon used for?+
Mestinon is prescribed primarily for the treatment of myasthenia gravis, a chronic autoimmune disorder that causes muscle weakness. By increasing acetylcholine levels at the neuromuscular junction, it helps improve voluntary muscle strength and reduces symptoms such as drooping eyelids and difficulty swallowing.
How does pyridostigmine work?+
Pyridostigmine is a reversible acetylcholinesterase inhibitor. It blocks the enzyme that degrades acetylcholine, thereby raising the concentration of this neurotransmitter at the neuromuscular junction. The increased acetylcholine enhances stimulation of nicotinic receptors, leading to stronger muscle contractions.
What is the usual dose of Mestinon?+
The dosage of Mestinon is individualized. A qualified prescriber determines the appropriate amount based on the patient’s clinical condition, severity of symptoms, renal function, and response to therapy. Patients should follow the prescribing physician’s instructions and not adjust the dose on their own.
Is Mestinon safe during pregnancy or breastfeeding?+
Safety data for pyridostigmine in pregnancy and lactation are limited. Healthcare providers weigh potential benefits against possible risks before prescribing it to pregnant or nursing women. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss their situation with a qualified clinician.
How do I order Mestinon from GNH USA?+
To place an order, submit an enquiry on the Mestinon product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.
How does Mestinon compare with other acetylcholinesterase inhibitors?+
Mestinon (pyridostigmine) is longer‑acting and generally better tolerated than neostigmine, another acetylcholinesterase inhibitor. Pyridoxine has a slower onset but provides more sustained symptom control, making it the preferred oral agent for chronic management of myasthenia gravis, whereas neostigmine is often used for short‑term or intra‑operative purposes.
How should Mestinon be stored and handled?+
Mestinon should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains sealed until use. Do not store in a refrigerator or freezer unless the manufacturer specifies otherwise.
How is Mestinon administered?+
Mestinon is taken orally, usually with a full glass of water. It can be administered with or without food, but consistent timing relative to meals helps maintain stable blood levels. Patients should swallow tablets whole and avoid crushing or chewing unless directed by a healthcare professional.
What are the most serious risks associated with Mestinon?+
The most critical adverse events include severe cholinergic crisis, which can cause profound muscle weakness, respiratory failure, and paralysis, and bradycardia, which may lead to fainting or cardiac complications. Prompt medical attention is required if patients experience sudden worsening of weakness, difficulty breathing, or a markedly slow heart rate.
Who should not use Mestinon?+
Mestinon is contraindicated in individuals with known hypersensitivity to pyridostigmine or any component of the formulation. It should also be avoided in patients with severe cardiac conduction disorders, such as untreated bradyarrhythmias, and in those taking high‑dose anticholinergic medications that could neutralize its effect.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Pyridostigmine Bromide
Route
Oral Use
Manufacturer
Viatris Ab
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU